Skip to content
Storytelling Co – Lifestyle
Author:
Antag Therapeutics
Antag Therapeutics appoints obesity treatment pioneer Philip Just Larsen as Chief Executive Officer
May 21, 2026
Antag Therapeutics to present data on AT7687, its first-in-class GIPR antagonist peptide at the American Diabetes Association’s 2026 Scientific Sessions
April 23, 2026